Mitchell McLeod Pugh & Williams’s GE HealthCare GEHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$234K Sell
3,662
-25
-0.7% -$1.64K 0.03% 288
2026
Q1
$262K Hold
3,687
0.04% 257
2025
Q4
$297K Sell
3,687
-4
-0.1% -$312 0.04% 251
2025
Q3
$293K Hold
3,691
0.05% 233
2025
Q2
$273K Hold
3,691
0.05% 235
2025
Q1
$298K Hold
3,691
0.06% 220
2024
Q4
$289K Buy
3,691
+21
+0.6% +$1.78K 0.06% 214
2024
Q3
$344K Hold
3,670
0.07% 206
2024
Q2
$286K Buy
3,670
+4
+0.1% +$326 0.07% 217
2024
Q1
$333K Buy
+3,666
New +$305K 0.08% 203

Other funds holding GEHC

Mitchell McLeod Pugh & Williams's GEHC Position: Q2 2026 in Review

Mitchell McLeod Pugh & Williams reduced its GE HealthCare (GEHC) stake by 0.68% in Q2 2026, selling an estimated $1.64K and leaving 3,662 shares worth $234K. The position accounts for 0.03% of the portfolio, ranked #288.

Mitchell McLeod Pugh & Williams first reported a position in GEHC in Q1 2024 and has held it in 10 quarters since. The position peaked at $344K in Q3 2024. 1,223 funds tracked by Wall St. Rank hold GEHC as of Q2 2026.

  • Mitchell McLeod Pugh & Williams held 3,662 shares of GE HealthCare worth $234K as of Q2 2026.
  • Mitchell McLeod Pugh & Williams sold 25 GE HealthCare shares in Q2 2026, an estimated $1.64K.
  • GE HealthCare made up 0.03% of Mitchell McLeod Pugh & Williams's portfolio in Q2 2026, its #288 holding.
  • Mitchell McLeod Pugh & Williams first reported a position in GE HealthCare in Q1 2024 and has held it in 10 quarters since.
  • Mitchell McLeod Pugh & Williams's GE HealthCare position peaked at $344K in Q3 2024.
  • 1,223 funds tracked by Wall St. Rank held GE HealthCare as of Q2 2026.

Based on Mitchell McLeod Pugh & Williams's 13F filing for Q2 2026, filed 11 Aug 2026.